Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 218 of 1,261
  1. US 11542320

    Nucleic acids encoding single domain antibodies to chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  2. US 11541002

    Oral film compositions and dosage forms having precise active dissolution profiles

    Aquestive Therapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  3. US 11542312

    IL-2 superagonists in combination with anti-PD-1 antibodies

    Medicenna Therapeutics Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  4. US 11542229

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  5. US 11542226

    Polyfunctional cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  6. US 11542261

    Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  7. US 11541044

    K-Ras modulators

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  8. US 11541125

    Noncrushable pill formulations

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  9. US 11541077

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  10. US 11541177

    Injection spring for aged prefilled syringe and auto injector

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  11. US 11541045

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  12. US 11542338

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  13. US 11542560

    Microbiome markers and therapies for autism spectrum disorders

    Board of Regents on Behalf of Arizona State University · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  14. US 11542238

    Pyrimidine cyclohexenyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  15. US 11542248

    Methods and compositions for inhibiting the interaction of menin with MLL proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  16. US 11542341

    Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  17. US 11542526

    Oncolytic adenoviral vector and methods of use

    Unleash Immuno Oncolytics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  18. US 11541032

    Composition containing sumo inhibitor and application

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  19. US 11542302

    Modulators of melanocortin receptors for the treatment of depression and anxiety

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  20. US 11542317

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  21. US 11534429

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  22. US 11533915

    Methods for making and using antimicrobial peptides

    Regents of the University of Minnesota · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  23. US 11534427

    Applications of novel thiazole derivative in treating inflammatory bowel diseases

    East China University of Science and Technology · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  24. US 11535849

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.